Commitments and Contingencies (Additional Information) (Details) - USD ($) $ in Millions			1 Months Ended
	Nov. 08, 2024	Jun. 17, 2024	Oct. 31, 2017	Sep. 30, 2024
Loss Contingencies [Line Items]
Shares issued for upfront payment		12,531,300
AstraZeneca [Member]
Loss Contingencies [Line Items]
Asset acquisition			$ 5.0
AstraZeneca [Member] | License Agreement [Member]
Loss Contingencies [Line Items]
Asset acquisition			$ 3.0
Shares issued for upfront payment			490,798
Maximum | AstraZeneca [Member]
Loss Contingencies [Line Items]
Maximum amount			$ 114.3
Subsequent Event [Member]
Loss Contingencies [Line Items]
Payments made under license agreement	$ 114.3
Subsequent Event [Member] | Amended AZ license agreement [Member]
Loss Contingencies [Line Items]
Shares issued for upfront payment	2,044,392
Payments made under license agreement	$ 0.5
CMOs [Member]
Loss Contingencies [Line Items]
Manufacturing commitments				$ 2.4